USITC Rules in Favor of JUUL in Patent Infringement Case

Feb.05
USITC Rules in Favor of JUUL in Patent Infringement Case
USITC rules against NJOY for e-cigarette patent infringement, issuing import and sales ban in favor of JUUL Labs.

Recently, the United States International Trade Commission (USITC) announced that it had ruled in favor of JUUL Labs in a patent infringement case against NJOY and its parent company Altria Group. The USITC issued a Limited Exclusion Order (LEO) and a Cease and Desist Order (CDO) that prohibit the import and sale of NJOY's infringing products. JUUL stated that the two orders will take effect on March 31, 2025.

 

According to the final ruling of the US International Trade Commission, NJOY has been found to have imported, sold, and distributed certain e-cigarette products in the US that infringe on four US patents owned by JUUL Labs.

 

United States Patent Number 11,134,722 (the '722 patent) — Infringement Claims: Claims 1 and 15.

 

U.S. Patent Number 11,606,981 (the '981 patent) - Infringement claims: Claims 1 and 8.

 

US Patent Number 10,130,123 (the '123 Patent') - Infringement Claims: Item 27 and Item 32.

 

U.S. Patent No. 10,709,173 ('173 Patent) - Infringement Claims: Claims 1 and 4.

 

The US International Trade Commission (USITC) has determined that defendants NJOY and its affiliated companies (NJOY, LLC, NJOY Holdings, Inc., Altria Group, Inc., Altria Group Distribution Company, Altria Client Services LLC) have imported, sold, and distributed infringing products in the US market without authorization, in violation of Section 337 of the Tariff Act of 1930 (19 U.S.C. 1337).

 

USITC ruling imposes a limited exclusion order (LEO) on NJOY's infringing products, prohibiting their importation into the United States, and imposes a cease and desist order (CDO) on NJOY and its parent company Altria, restricting their sales of related products in the US market.

 

JUUL Labs and its affiliate VMR Products LLC played a crucial role in this case. Tyler Mace, Chief Legal Officer of Juul Labs, released the following statement:

 

“We are pleased by the ITC’s decision to protect our U.S.-developed innovations against those who seek to import copycat products, principally from China. We welcome fair competition in our mission to switch adult smokers away from combustible cigarettes, but we must protect our valuable intellectual property against the deliberate freeriding on our investments in homegrown U.S. technology. Today’s ruling sends a clear message that this freeriding violates U.S. law and American innovation will be protected.”

 

If there are any further developments, 2Firsts will continue to follow and report on the story.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.